Drug‐eluting stents vs bare stents: Serious adverse events maximum
Drug‐eluting stents may leads to lower serious adverse events at maximum compared with bare‐metal stents (low certainty).
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Drug‐eluting stents vs bare‐metal stents Serious adverse events at maximum · People with acute coronary syndrome Drug‐eluting stents may leads to lower serious adverse events at maximum compared with bare‐metal stents (low certainty). Drug‐eluting stents versus bare‐metal stents for acute coronary syndrome (2017) · Cochrane Headline outcomes only | RR 0.8 [0.74, 0.86] | 22 studies · 11724 participants | Low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Drug‐eluting stents versus bare‐metal stents for acute coronary syndrome 2017 · Cochrane Headline outcomes only | Not reported | list not extracted yet | Not assessed |
Studies behind the findings
None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.